Summary
The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck’s cancer drug to treat two types adrenal gland tumors.
Source: Reuters on MSN.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
